IDEXX Laboratories, Inc.
IDXX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $4.30B | $3.90B | +10.4% |
| Operating income | $1.36B | $1.13B | +20.5% |
| Net income | $1.06B | $888M | +19.3% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $1.21B | $1.11B | +9.9% |
| Operating income | $402M | $355M | +13.4% |
| Net income | $317M | $275M | +15.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was IDEXX's revenue in FY2025?
- $4.30B in FY2025 (Fiscal year ended Dec 31, 2025), +10.4% vs $3.90B a year earlier, per its 10-K filed Feb 2026.
- Was IDEXX profitable in FY2025?
- Yes: net income was $1.06B and operating income $1.36B in FY2025.
- What was IDEXX's revenue in Q3 2026?
- $1.21B (+9.9% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.